Table 1. Baseline Characteristics of Subjects.
| Subject Characteristics | Cohort Followed Until Discharge (n=166) | Cohort Followed Until 6 Months (n=102) |
|---|---|---|
| Time between onset and initial assessment (median [IQR] in hours) | 2.3 [0.7-5.3] | |
| Time between baseline and outcome assessment (median in days) | 5 | 192 |
| Clinical Variables | ||
| Age (mean in years) | 68.2 | 67.7 |
| Male (n,%) | 83 (50.0%) | 55 (53.9%) |
| BMI (mean in kg/m2) | 26.9 | 26.8 |
| Prestroke mRS (median (mean)) | 0 (0.55) | 0 (0.48) |
| Prestroke mRS>0 (n,%) | 46 (27.7%) | 25 (24.5%) |
| Prestroke mRS>1 (n,%) | 26 (15.7%) | 13 (12.7%) |
| Initial NIHSS<5 (n,%) | 41 (24.7%) | 29 (28.4%) |
| Isolated aphasia (n,%) | 17 (10.2%) | 14 (13.7%) |
| Mild to moderate aphasia (n,%) | 71 (42.8%) | 51 (50.0%) |
| Severe aphasia to mute (n,%) | 95 (57.2%) | 51 (50.0%) |
| R arm weakness (n,%) | 87 (52.4%) | 51 (50.0%) |
| Received IV tPA or intra-arterial therapy (n,%) | 47 (28.3%) | 30 (29.4%) |
| Imaging Variables | ||
| UECT ASPECTS score (median) | 9 (7.98) | 9 (8.09) |
| CTA-SI ASPECTS score (median) | 8 (7.57) | 8 (7.75) |
| Other UECT hypodense regions (median) | 0 (0.34) | 0 (0.37) |
| Other CTA-SI hypodense regions (median) | 0 (0.52) | 0 (0.48) |
| Medical and Social History Variables | (n=151) | (n=90) |
| History of smoking (n,%) | 73 (48.3%) | 40 (44.4%) |
| Consumes alcohol more than occasionally (n,%) | 31 (20.5%) | 16 (17.8%) |
| Sedentary activity level (n,%) | 54 (35.8%) | 31 (34.4%) |
| Working full time (n,%) | 42 (27.8%) | 24 (26.7%) |
| Completed education beyond high school (n,%) | 58 (38.4%) | 38 (42.2%) |
| Taking antiplatelet agent (n,%) | 62 (41.1%) | 37 (41.1%) |
| Taking warfarin (n,%) | 16 (10.6%) | 13 (14.4%) |
| History of prior stroke (n,%) | 10 (6.6%) | 5 (5.6%) |
| History of cardiovascular disease (n,%) | 12 (7.9%) | 8 (8.9%) |
There were no significant differences between the baseline characteristics of the cohort followed until discharge and the cohort followed until 6 months.